DexCom earnings beat by $0.03, revenue topped estimates
In a challenging market environment, MediaAlpha Inc. shares have touched a 52-week low, sinking to $8.64, with the stock currently trading at $8.69. The stock has fallen dramatically from its 52-week high of $25.78, with analyst price targets ranging from $13 to $27. According to InvestingPro analysis, the stock appears undervalued at current levels. This latest price level reflects a significant downturn for the company, which has seen its stock value erode by -54.85% over the past year, with a year-to-date decline of 22.5%. Investors are closely monitoring the stock as it struggles to find a foothold after a prolonged period of bearish trends. The 52-week low serves as a critical indicator of the company’s current market position and the broader sentiment surrounding its performance and future prospects. For deeper insights into MediaAlpha’s valuation metrics and growth potential, investors can access the comprehensive Pro Research Report available on InvestingPro, which covers over 1,400 US stocks with detailed analysis and actionable intelligence.
In other recent news, MediaAlpha Inc. has reported mixed financial results for the fourth quarter of 2024. The company posted earnings per share of $0.08, which fell short of the consensus estimate of $0.22. However, revenue exceeded expectations, coming in at $300.6 million compared to the anticipated $298.3 million, marking a 157% year-over-year increase. The transaction value for the quarter reached a record $499.2 million, driven by a 639% year-over-year growth in the Property & Casualty insurance vertical. Despite these gains, MediaAlpha’s forward-looking guidance suggests a potential slowdown, with first-quarter 2025 revenue forecasted between $225 million and $245 million, below the consensus estimate of $268.6 million.
Analysts have responded to these developments with adjustments to their outlooks. Goldman Sachs lowered its price target for MediaAlpha shares to $14.00 from $23.00, maintaining a Buy rating, while Keefe, Bruyette & Woods reduced their target to $19.00 from $22.00, keeping an Outperform rating. These revisions reflect the cautious near-term guidance and ongoing Federal Trade Commission (FTC) inquiry into MediaAlpha’s Health segment. The company has reserved $7.0 million related to the FTC matter, which remains a point of focus for investors. Despite the challenges, MediaAlpha’s CEO, Steve Yi, expressed confidence in the company’s growth prospects, particularly in the auto insurance advertising market.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.